%0 Journal Article
%T Clinical Efficacy of LivPro ® Herbal Medicine among Hepatitis C Patients Pakistan: Longitudinal Interventional Study
%A Irfan Shahid
%A Kashif Maqbool Khan
%A Tahir Mehmood Khan
%A Muhammad Saeed Imran
%A Nabeel Shahid
%A Farah Nofal Alnafoosi
%A Mirza Rafi Baig
%A Yaser Mohammed Al-Worafi
%J Archives of Pharmacy Practice
%@ 2320-5210
%D 2021
%V 12
%N 4
%R 10.51847/v5lmbrLQNQ
%P 54-57
%X The current study aims to investigate the hepatoprotective effects of LivPro® among hepatitis C patients. An interventional study was performed among n=89 hepatitis C patients. The duration of the study was 3 months and the assessment for liver function, ELISA, and Viral load was performed monthly for the patients recruited in this study. Mean difference was measured and at a Confidence Interval (CI 95%) p-value less than 0.05 was considered statistically significant. This interventional study was comprised of 89 patients who directly participated in this study. Of whom 52 (58.0%) were men and the remaining 42% were women. All the patients were hepatitis C positive at the time of recruitment of study. Overall, it is observed that improvement in ALT at the endpoint assessment was -23.13 [ -31.96 - -14.30] in comparison to the baseline (p=
%U https://archivepp.com/article/clinical-efficacy-of-livpro-herbal-medicine-among-hepatitis-c-patients-pakistan-longitudinal-inter-pug7gi6fsski3c2